ESPAÑOL ENGLISH

Betancor Quintana, Gilberto Jose

Publicaciones

All

Articles

Review

Annotation

Lecture

Others

Type

By researcher

By affiliation

Title Issue Date
Editorial: Factores del huésped implicados en la infección viral Jimenez-Guardeño, Jose M.; Menéndez-Arias, Luis; Betancor Quintana, Gilberto Jose Issued date: 2024 DOI: 10.3389/fmicb.2024.1382503 Source: Frontiers in Microbiology [EISSN 1664-302X], v. 15, (Enero 2024) SJR: 1,065 - Q1 JCR: 5,2 - Q2 SCIE MIAR ICDS: 10,5 Comentario
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription Arribas Ruscalleda, Laura ; Menendez-Arias, Luis; Betancor Quintana, Gilberto Jose Issued date: 2024 DOI: 10.3390/ijms25137167 Source: International Journal Of Molecular Sciences [ISSN 1661-6596], v. 25 (13), (Julio 2024) SJR: 1,179 - Q1 JCR: 5,6 - Q1 SCIE MIAR ICDS: 10,8 Artículo
You Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors Betancor Quintana, Gilberto Jose Issued date: 2023 DOI: 10.3390/vaccines11050930 Source: Vaccines [EISSN 2076-393X], v. 11 (5), 930, (Mayo 2023) SJR: 1,201 - Q1 JCR: 7,8 - Q1 SCIE MIAR ICDS: 10,4 Artículo
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Volz, Erik; Hill, Verity; McCrone, John T.; Price, Anna; Jorgensen, David, et al Issued date: 2021 DOI: 10.1016/j.cell.2020.11.020 Source: Cell [ISSN 0092-8674] , v. 184 (1), p. 64-75 e11 (Enero 2021) SJR: 25,716 - Q1 JCR: 66,85 - Q1 SCIE Artículo
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA, et al Issued date: 2021 DOI: 10.1016/s1473-3099(21)00475-8 Source: The Lancet Infectious Diseases [1473-3099], v. 22(1), pp. 35-42 (Agosto 2021) SJR: 10,236 - Q1 JCR: 71,421 - Q1 SCIE MIAR ICDS: 10,8 Artículo
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome Shaw, Andrew M.; Hyde, Christopher; Merrick, Blair; James-Pemberton, Philip; Squires, Bethany K., et al Issued date: 2020 DOI: 10.1039/D0AN01066A Source: Analyst [0003-2654], v. 145 (16), pp. 5638-5646 (Julio 2020) SJR: 0,998 - Q1 JCR: 4,616 - Q1 SCIE Artículo
The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction Betancor Quintana, Gilberto Jose ; Dicks, MDJ; Jimenez-Guardeño, JM; Ali, NH; Apolonia, L, et al Issued date: 2019 DOI: 10.1016/j.celrep.2019.10.009 Source: Cell Reports [2211-1247], v. 29(7), p. 1923-1933 (Noviembre 2019) SJR: 6,058 - Q1 JCR: 8,109 - Q1 SCIE Artículo
Immunoproteasome activation enables human TRIM5α restriction of HIV-1 Jimenez-Guardeño, JM; Apolonia, L; Betancor Quintana, Gilberto Jose ; Malim, MH Issued date: 2019 DOI: 10.1038/s41564-019-0402-0 Source: Nature Microbiology [2058-5276], v. 4, p. 933-940 (Marzo 2019) SJR: 7,922 - Q1 JCR: 15,54 - Q1 SCIE Artículo
Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction Dicks, MDJ; Betancor Quintana, Gilberto Jose ; Jimenez-Guardeño, JM; Pessel-Vivares, L; Apolonia, L, et al Editor: Emerman, Michael Issued date: 2018 DOI: 10.1371/journal.ppat.1007408 Source: PLoS Pathogens [1553-7366], v. 14(11): e1007408 (Noviembre 2018) SJR: 3,909 - Q1 JCR: 6,463 - Q1 SCIE Artículo
Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis Betancor Quintana, Gilberto Jose ; Alvarez, M; Marcelli, B; Andrés, C; Martínez, MA, et al Issued date: 2015 DOI: 10.1093/nar/gkv077 Source: Nucleic Acids Research [0305-1048], v. 43(4), p. 2259-2270 (Febrero 2015) SJR: 7,239 - Q1 JCR: 9,202 - Q1 SCIE Artículo
Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients Betancor Quintana, Gilberto Jose ; Nevot, M.; Mendieta, J.; Gómez-Puertas, P.; Martínez, M.A., et al Issued date: 2014 DOI: 10.1016/j.antiviral.2014.03.004 Source: Antiviral Research [ISSN 0166-3542], v. 106, pp. 42-52 (Junio 2014) SJR: 1,645 - Q1 JCR: 3,938 - Q1 SCIE Artículo
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy Betancor Quintana, Gilberto Jose ; Garriga, C; Puertas, MC; Nevot, M; Anta, L, et al Issued date: 2012 DOI: 10.1186/1742-4690-9-68 Source: Retrovirology [1742-4690], v. 9:68 (agosto 2012) SJR: 2,313 - Q2 JCR: 5,657 - Q1 SCIE Artículo
HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors Menéndez-Arias, L; Betancor Quintana, Gilberto Jose ; Matamoros, T Issued date: 2011 DOI: 10.1016/j.antiviral.2011.08.020 Source: Antiviral Research [0166-3542], v. 92(2), p. 139-149 (Noviembre 2011) SJR: 1,61 - Q1 JCR: 4,301 - Q1 SCIE Reseña
Reverse Transcriptase and Retroviral Replication Matamoros, Tania; Álvarez, Mar; Barrioluengo, Verónica; Betancor Quintana, Gilberto Jose ; Menéndez-Arias, Luis Issued date: 2011 DOI: 10.5772/21660 Source: DNA Replication and Related Cellular Processes / Kusic-Tisma, Jelena (Ed.), p. 111-142 (septiembre 2011). Capítulo de libro
A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy Paredes, R.; Puertas, M.C.; Bannister, W.; Kisic, M.; Cozzi-Lepri, A., et al Issued date: 2011 DOI: 10.1093/infdis/jir385 Source: Journal of Infectious Diseases [ISSN 1537-6613], v. 204 (5), pp. 741-752 (Septiembre 2011) SJR: 3,535 - Q1 JCR: 6,41 - Q1 SCIE Artículo
Mechanisms Involved in the Selection of HIV-1 Reverse Transcriptase Thumb Subdomain Polymorphisms Associated with Nucleoside Analogue Therapy Failure Betancor Quintana, Gilberto Jose ; Puertas, MC; Nevot, M; Garriga, C; Martínez, MA, et al Issued date: 2010 DOI: 10.1128/AAC.00716-10 Source: Antimicrobial Agents and Chemotherapy [0066-4804], v. 54(11), p. 4799-4811 (Noviembre 2010) JCR: 4,672 - Q1 SCIE Artículo